
Joint Announcement
Maven VCT Offers Fully Subscribed
Joint Announcement by Maven Income and Growth VCT PLC, Maven Income and Growth VCT 3 PLC, Maven Income and Growth VCT 4 PLC and Maven Income and Growth VCT 5 PLC (each a VCT and together the Maven VCTs).
On 27 September 2024, the Maven VCTs announced the publication of a joint Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to an offer for subscription of new Ordinary Shares of 10p each (the "Offers").
On 27 March 2025, the Boards of the Maven VCTs advised that applications had been received for the full amounts available under the Maven VCT 1 and Maven VCT 5 Offers and, as such, the Maven VCT 1 and Maven VCT 5 Offers were closed for further applications. The Boards can now confirm that applications have now been received for the full amounts available under the Maven VCT 3 and Maven VCT 4 Offers and, as such, the Maven VCT Offers are now all closed for further applications.
Any enquiries in respect of the Offers should be directed to:
Maven Capital Partners UK LLP
Kintyre House
205 West George Street
Glasgow
G2 2LW
Telephone: 0141 306 7400
E-mail: enquiries@mavencp.com
Maven Capital Partners UK LLP
Secretary
1 April 2025
The information contained within this announcement is deemed by the Companies to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.
Notes
This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.